177 related articles for article (PubMed ID: 22004633)
1. Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.
Egberts F; Hartje C; Schafmayer C; Kaehler KC; von Schönfels W; Hauschild A; Becker T; Egberts JH
Ann R Coll Surg Engl; 2011 Oct; 93(7):514-22. PubMed ID: 22004633
[TBL] [Abstract][Full Text] [Related]
2. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
3. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
[TBL] [Abstract][Full Text] [Related]
4. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
5. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
6. Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Theodore JE; Frankel AJ; Thomas JM; Barbour AP; Bayley GJ; Allan CP; Wagels M; Smithers BM
ANZ J Surg; 2017 Jan; 87(1-2):44-48. PubMed ID: 27102082
[TBL] [Abstract][Full Text] [Related]
7. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
8. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
9. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature.
Moody JA; Botham SJ; Dahill KE; Wallace DL; Hardwicke JT
Eur J Surg Oncol; 2017 Sep; 43(9):1760-1767. PubMed ID: 28756017
[TBL] [Abstract][Full Text] [Related]
10. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
12. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
[TBL] [Abstract][Full Text] [Related]
13. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection.
Kretschmer L; Thoms KM; Peeters S; Haenssle H; Bertsch HP; Emmert S
Melanoma Res; 2008 Feb; 18(1):16-21. PubMed ID: 18227703
[TBL] [Abstract][Full Text] [Related]
15. Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.
Verver D; Madu MF; Oude Ophuis CMC; Faut M; de Wilt JHW; Bonenkamp JJ; Grünhagen DJ; van Akkooi ACJ; Verhoef C; van Leeuwen BL
Br J Surg; 2018 Jan; 105(1):96-105. PubMed ID: 29095479
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
[TBL] [Abstract][Full Text] [Related]
18. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
19. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).
Faries MB; Thompson JF; Cochran A; Elashoff R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ; Morton DL;
Ann Surg Oncol; 2010 Dec; 17(12):3324-9. PubMed ID: 20614193
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
